Finance

Lists
Why is I1DX34 up 2,81%?
Dive Deeper
I1DX34:BVMF
Idexx Laboratories Inc Bdr
546,43 R$
+2,81%
(+14,92) 1D
15 հոկ, 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for I1DX34...
Open
544,31 R$
High
546,43 R$
Low
544,31 R$
Mkt. cap
43,11 մլրդ
Avg. vol.
6,00
Volume
3,00
52-wk high
813,60 R$
52-wk low
509,99 R$
Shares outstanding
78,78 մլն
No. of employees
11 հզր
Open
544,31 R$
High
546,43 R$
Low
544,31 R$
Mkt. cap
43,11 մլրդ
Avg. vol.
6,00
Volume
3,00
52-wk high
813,60 R$
52-wk low
509,99 R$
Shares outstanding
78,78 մլն
No. of employees
11 հզր
News stories
From web sources and news partners
Profile
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs about 11,000 people in full-and part-time positions. In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO. In 2025, IDEXX estimated annual sales between $4.21 billion and $4.28 billion, with total quarterly revenue exceeding $1 billion. Wikipedia
About Idexx Laboratories Inc Bdr
CEOJay Mazelsky
Employees11 հզր
Founded19 դեկ, 1983 թ.
HeadquartersWestbrook, Մեն, Միացյալ Նահանգներ
Sector-
Websiteidexx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,11 մլրդ
1,09 մլրդ
1,14 մլրդ
1,22 մլրդ
Cost of goods sold
421,88 մլն
432,46 մլն
418,08 մլն
437,50 մլն
Cost of revenue
421,88 մլն
432,46 մլն
418,08 մլն
437,50 մլն
Research and development expenses
63,42 մլն
66,83 մլն
65,79 մլն
65,43 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
265,09 մլն
266,68 մլն
294,36 մլն
288,09 մլն
Operating expense
328,51 մլն
333,51 մլն
360,15 մլն
353,52 մլն
Total operating expenses
750,39 մլն
765,97 մլն
778,23 մլն
791,02 մլն
Operating income
354,85 մլն
324,60 մլն
362,59 մլն
425,57 մլն
Other non operating income
-
-
-
-
EBT including unusual items
344,77 մլն
306,98 մլն
355,44 մլն
417,22 մլն
EBT excluding unusual items
344,77 մլն
315,98 մլն
355,44 մլն
415,99 մլն
Income tax expense
70,16 մլն
58,79 մլն
77,00 մլն
78,81 մլն
Effective tax rate
20,35%
19,15%
21,66%
18,89%
Other operating expenses
-
-
-
-
Net income
274,61 մլն
248,19 մլն
278,45 մլն
338,41 մլն
Net profit margin
24,85%
22,76%
24,41%
27,82%
Earnings per share
3,40
3,08
3,47
4,27
Interest and investment income
580,00 հզր
587,00 հզր
597,00 հզր
606,00 հզր
Interest expense
-10,66 մլն
-9,21 մլն
-7,74 մլն
-10,18 մլն
Net interest expenses
-10,08 մլն
-8,62 մլն
-7,14 մլն
-9,58 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
391,47 մլն
363,33 մլն
400,27 մլն
466,62 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps